Compare · FTXH vs HCXY
FTXH vs HCXY
Side-by-side comparison of First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Hercules Capital, Inc. (HCXY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both FTXH and HCXY operate in n/a (n/a), so they compete in similar markets.
- HCXY carries a market cap of $4.54B.
- Over the past year, FTXH is up 47.9% and HCXY is down 1.0% - FTXH leads by 49.0 points.
- HCXY has hit the wire 5 times in the past 4 weeks while FTXH has been quiet.
First Trust Nasdaq Pharmaceuticals ETF
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.
Latest FTXH
- Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
- First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds
- First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds
- First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds
- First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds
- First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds
- First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds
- First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds
Latest HCXY
- Hercules Capital Reports Second Quarter 2026 Financial Results
- Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Second Quarter 2026
- Hercules Capital Closes Institutional Notes Offering of $325.0 Million 6.300% Unsecured Notes due 2031
- Hercules Capital Prices Institutional Notes Offering of $325.0 Million 6.300% Notes due 2031
- Hercules Capital Announces Date for Release of Second Quarter 2026 Financial Results and Conference Call
- Hercules Capital Announces Date of 2026 Annual Meeting of Stockholders
- Hercules Capital Reports First Quarter 2026 Financial Results
- Hercules Capital Enters Next Phase of Growth with Expanded Leadership Team
- Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the First Quarter 2026
- Hercules Capital Announces Date for Release of First Quarter 2026 Financial Results and Conference Call